From Evan Harris <[email protected]>
Subject Bernie Sanders’ ‘Medicare-for-all’ means worse health insurance at higher cost for most Americans
Date September 9, 2019 5:44 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])
[link removed]

Bernie Sanders’ ‘Medicare-for-all’ means worse health insurance at higher cost for most Americans

Fox News | Sally C. Pipes
September 9, 2019

About 180 million Americans get health coverage through their employer. Knowingly or not, each of these workers has sacrificed higher salaries in exchange for health insurance. Most of them are not going to get government-ordered pay increases under “Medicare-for-all.”

Read more . . . ([link removed])

Defining a Medicines’ Value versus its Price

Forbes | Wayne Winegarden
September 5, 2019

Ultimately, the value of a medicine can only be discovered through an interactive process that connects the costs facing innovative manufacturers with the benefits provided to patients. Policy reforms that remove these obstacles are, consequently, necessary.

Read more . . . ([link removed])

The saga of Dr. Brian Day and his illegal private clinic in Canada

Fierce Healthcare | Sally C. Pipes
September 6, 2019

If Day prevails, Canadians could finally gain the ability to access timely care—something their government routinely denies them. But win or lose, his case illuminates for Americans the pitfalls of government-run healthcare.

Read more . . . ([link removed])

We Need A Regulatory Reformer to Head The FDA

Issues and Insights | Henry Miller, M.S., M.D.
September 5, 2019

According to sources, there are three candidates being considered — two academics and the current acting commissioner, who was previously the director of the National Cancer Institute at the National Institutes of Health. This transition offers an opportunity: We need an aggressive regulatory reformer.

Read more . . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2019 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis